Clinical Trials Directory

Trials / Terminated

TerminatedNCT01644136

Microspheres in Preventing Lymphatic Fluid Collection After Surgery in Patients With Prostate Cancer

A Pilot Clinical Trial for the Prevention of Postoperative Lymphoceles Using Absorbable Micorporous Polysaccharide Hemosphere Particles During Robotic Assisted Prostatectomy With Lymph Node Dissection

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
99 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
Male
Age
Healthy volunteers
Not accepted

Summary

This study is being performed to investigate if the application of Arista absorbable hemostat (AH)®, a product approved to stop surgical bleeding, can prevent lymphoceles. Lymphoceles are collections of lymphatic fluid which can occur after a lymph node dissection for cancer. These fluid collections can become symptomatic in some patients. Arista would be applied to one side of the pelvis after a pelvic lymph node dissection, to see if this decreases the number of postoperative lymph fluid collections seen on a computed tomography (CT) scan after surgery

Detailed description

PRIMARY OBJECTIVES: I. To determine whether, if applied to the lymph node basins after pelvic lymph node dissection, Arista could potentially reduce the formation of lymphoceles and consequently the need for secondary interventions. OUTLINE: Patients undergo standard robotic assisted laparoscopic prostatectomy with pelvic lymph node dissection. After lymph node dissection, patients undergo microsphere-mediated lymphocele prevention to the lymph node basin on one side of the pelvis. After completion of study treatment, patients are followed up at 3 months.

Conditions

Interventions

TypeNameDescription
PROCEDURErobot-assisted laparoscopic surgeryUndergo standard robotic assisted laparoscopic prostatectomy
PROCEDUREregional lymph node dissectionUndergo pelvic lymph node dissection
DEVICEmicrosphere-mediated lymphocele preventionUndergo microsphere-mediated lymphocele prevention

Timeline

Start date
2011-07-14
Primary completion
2014-05-06
Completion
2014-05-06
First posted
2012-07-18
Last updated
2018-06-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01644136. Inclusion in this directory is not an endorsement.